US Map / Kansas
State KS

Clinical Trials in Kansas

Kansas is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Kansas and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 108 actively recruiting studies with Kansas sites out of 108 registered in total. The busiest research areas in Kansas are Head and Neck Cancer, Prostate Cancer, Heart Failure. Leading sponsors running trials in the state include University of Kansas Medical Center, National Cancer Institute (NCI), Incyte Corporation. By stage, Kansas trials break down as Phase 1 (24), Phase 2 (33), Phase 3 (33), Phase 4 (3).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
108
Recruiting Now
108
← Back to US Map
Top Conditions in Kansas
Head and Neck Cancer (3)Prostate Cancer (3)Heart Failure (3)Cystic Fibrosis (CF) (3)Obesity (3)Esophageal Cancer (2)Ovarian Cancer (2)Sarcoma (2)Acute Myeloid Leukemia (AML) (2)Diabetes Mellitus, Type 2 (2)Parkinson Disease (2)Systemic Lupus Erythematosus (2)

Frequently Asked Questions — Clinical Trials in Kansas

How many clinical trials are currently recruiting in Kansas?
ClinicalMetric currently tracks 108 actively recruiting clinical trials with at least one location in Kansas. The total number of registered studies—including active but not currently enrolling trials—is 108. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Kansas?
Kansas hosts clinical trials across a broad range of medical conditions, including Head and Neck Cancer, Prostate Cancer, Heart Failure, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Kansas serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Kansas?
To join a clinical trial in Kansas, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Kansas maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Kansas

NCT07174453 Phase 3
Recruiting
Trial to Evaluate irAEs With Different Standard of Care Dosing Strategies of Sta...
Condition
Solid Tumor Malignancies
Enrollment
192 pts
Location
United States
Sponsor
University of Kansas Medical C
View Trial →
NCT06585774 Phase 3
Recruiting
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chro...
Condition
Chronic Graft-versus-host-disease
Enrollment
240 pts
Location
United States, Australia, Austria
Sponsor
Incyte Corporation
View Trial →
NCT03816345 Phase 1
Recruiting
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Pa...
Condition
Autoimmune Disease
Enrollment
300 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT04333537 Phase 2, Phase 3
Recruiting
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Pat...
Condition
Buccal Mucosa Squamous Cell Carcinoma
Enrollment
686 pts
Location
United States, Canada
Sponsor
NRG Oncology
View Trial →
NCT06500273 Phase 2
Recruiting
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Condition
Large B-cell Lymphoma
Enrollment
250 pts
Location
United States, Australia, Canada
Sponsor
Allogene Therapeutics
View Trial →
NCT07729462 Phase 3
Recruiting
A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used ...
Condition
Preventive Treatment of Migraine
Enrollment
400 pts
Location
United States, Israel
Sponsor
Pfizer
View Trial →
NCT04373057 Phase 1, Phase 2
Recruiting
Prebiotic Galacto-oligosaccharide and Acute GVHD
Condition
Acute GVHD
Enrollment
128 pts
Location
United States
Sponsor
University of Kansas Medical C
View Trial →
NCT06064877 Phase 3
Recruiting
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recur...
Condition
Metastatic Head-and-neck Squamous-cell Carcinoma
Enrollment
410 pts
Location
United States, Australia, Belgium
Sponsor
AVEO Pharmaceuticals, Inc.
View Trial →
Page 5 of 5 — 108 trials total
← Prev
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology